1. Biological roles and therapeutic potential of G protein-coupled receptors for free fatty acids and metabolic intermediates
    Kenji Suzuki et al, 2016, JPFSM CrossRef
  2. Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System
    Jocelyn L. Tan-Shalaby et al, 2016, Nutr Metab (Lond) CrossRef
  3. Investigational new drugs for brain cancer
    Verena Staedtke et al, 2016, Expert Opinion on Investigational Drugs CrossRef
  4. Systematic review: isocaloric ketogenic dietary regimes for cancer patients
    N. Erickson et al, 2017, Med Oncol CrossRef
  5. Krebsdiäten
    J. Hübner, 2014, Forum CrossRef
  6. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study
    Moran Artzi et al, 2017, J Neurooncol CrossRef
  7. Ketogenic Diet and Cancer-a Perspective.
    Christopher Smyl, 2016 CrossRef
  8. Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs
    C von Neubeck et al, 2015, BJR CrossRef
  9. Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials
    Amir Zahra et al, 2017, Radiation Research CrossRef
  10. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature
    Kenneth Schwartz et al, 2015, Cancer Metab CrossRef
  11. Personalized translational epilepsy research — Novel approaches and future perspectives
    Felix Rosenow et al, 2017, Epilepsy & Behavior CrossRef
  12. null
    Joshua D. Palmer et al, 2016 CrossRef
  13. Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment
    Hae-Yun Chung et al, 2017, J Cancer Prev CrossRef
  14. Role of ketogenic metabolic therapy in malignant glioma: A systematic review
    Sebastian F. Winter et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
  15. Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study
    Kirsty J. Martin-McGill et al, 2017, Pilot Feasibility Stud CrossRef
  16. Obesity and Cancer Mechanisms: Cancer Metabolism
    Benjamin D. Hopkins et al, 2016, JCO CrossRef
  17. Effect of ketogenic diets on leukocyte counts in patients with epilepsy
    Karisa C. Schreck et al, 2017, Nutritional Neuroscience CrossRef
  18. Ketogenic diet for primary brain and spinal cord tumours
    Calleigh H Reardon et al, 2017 CrossRef
  19. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Angela Poff et al, 2019, Semin Cancer Biol CrossRef
  20. The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: A case series in general practice
    NATALIE JANSEN et al, 2016 CrossRef
  21. Wirksamkeit der ketogenen Diät bei urologischen Tumorerkrankungen
    P. Maisch et al, 2018, Urologe CrossRef
  22. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma
    Jule A. Eriksson et al, 2018, J. Neurochem. CrossRef
  23. The Pro-tumorigenic Effects of Metabolic Alterations in Glioblastoma Including Brain Tumor Initiating Cells
    Catherine J. Libby et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  24. A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice
    , 2018, Nutrients CrossRef
  25. A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review
    Camila L.P. Oliveira et al, 2017, Journal of the Academy of Nutrition and Dietetics CrossRef
  26. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up
    Ahmed M. A. Elsakka et al, 2018, Front. Nutr. CrossRef
  27. The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review
    Kirsty J Martin-McGill et al, 2018, CNS Oncology CrossRef
  28. The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service
    Kirsty J. Martin-McGill et al, 2018, Nutrition and Cancer CrossRef
  29. Fasting and its Therapeutic Impact in Brain Tumors
    Carla Venegas-Borsellino et al, 2018, Curr Surg Rep CrossRef
  30. Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation
    Catharina Bartmann et al, 2018, Cancer Metab CrossRef
  31. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance
    Evan K. Noch et al, 2018, World Neurosurgery CrossRef
  32. Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients
    Rainer J. Klement et al, 2018, Theor Biol Med Model CrossRef
  33. A systematic review of the use of ketogenic diets in adult patients with cancer
    J. Sremanakova et al, 2018, J Hum Nutr Diet CrossRef
  34. The Expanding Role of Ketogenic Diets in Adult Neurological Disorders
    Tanya McDonald et al, 2018, Brain Sciences CrossRef
  35. Wilhelm Brünings' forgotten contribution to the metabolic treatment of cancer utilizing hypoglycemia and a very low carbohydrate (ketogenic) diet
    Rainer Johannes Klement, 2018, Journal of Traditional and Complementary Medicine CrossRef
  36. Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet
    Martin Voss et al, 2018, IJMS CrossRef
  37. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects
    Annegret Kathagen-Buhmann et al, 2018 CrossRef
  38. Ketogenic Diets for Adult Neurological Disorders
    Tanya J. W. McDonald et al, 2018, Neurotherapeutics CrossRef
  39. Fasting and cancer: molecular mechanisms and clinical application
    Alessio Nencioni et al, 2018, Nat Rev Cancer CrossRef
  40. Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies
    Lotte Noorlag et al, 2018, Clinical Nutrition CrossRef
  41. Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease
    Jason Brandt et al, 2019, JAD CrossRef
  42. Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas
    Alberto Azzalin et al, 2017, Neoplasia CrossRef
  43. Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer
    Mehmet Salih Iyikesici, 2019, International Journal of Hyperthermia CrossRef
  44. Trial watch: Dietary interventions for cancer therapy
    Sarah Lévesque et al, 2019, OncoImmunology CrossRef
  45. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
    Thomas N. Seyfried et al, 2019, Neurochem Res CrossRef
  46. Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer
    R J Klement et al, 2016, Oncogenesis CrossRef
  47. null
    Elke Hattingen et al, 2014 CrossRef
  48. Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study
    Elles J. T. M. van der Louw et al, 2019, Ther Adv Med Oncol CrossRef
  49. Pancreatic Cancer Cachexia: The Role of Nutritional Interventions
    Toni Mitchell et al, 2019, Healthcare CrossRef
  50. Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
    null Saenz-Antoñanzas et al, 2019, Cancers CrossRef
  51. Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors
    Roy E. Strowd et al, 2015 CrossRef
  52. A Ketogenic Diet Is Acceptable in Women with Ovarian and Endometrial Cancer and Has No Adverse Effects on Blood Lipids: a Randomized, Controlled Trial
    Caroline W. Cohen et al, 2019, Nutrition and Cancer CrossRef
  53. Ketogenic diet in the treatment of cancer – Where do we stand?
    Daniela D. Weber et al, 2019, Molecular Metabolism CrossRef
  54. Dietary restriction during the treatment of cancer: results of a systematic scoping review
    Ellie Shingler et al, 2019, BMC Cancer CrossRef
  55. Commentary on “Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme”
    Colin E Champ et al, 2015, Strahlenther Onkol CrossRef
  56. Treatment Options for Optic Pathway Gliomas
    Reena P. Thomas et al, 2015, Curr Treat Options Neurol CrossRef
  57. Mitochondria: The ketogenic diet—A metabolism-based therapy
    Silvia Vidali et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
  58. Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model
    Raphael Johannes Morscher et al, 2015, PLoS ONE CrossRef
  59. The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors
    Roy E. Strowd et al, 2015, Curr. Treat. Options in Oncol. CrossRef
  60. Lebenszeit verlängern und Symptome von Hirnmetastasen lindern
    Peter Hau et al, 2015, InFo Neurologie CrossRef
  61. Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma
    Peter M. Clark et al, 2016, Curr Neurol Neurosci Rep CrossRef
  62. Therapeutic options in recurrent glioblastoma—An update
    Katharina Seystahl et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
  63. Ketogenic diets: from cancer to mitochondrial diseases and beyond
    Ana F. Branco et al, 2016, Eur J Clin Invest CrossRef
  64. Highlights from the Literature
    , 2016, Neuro Oncol CrossRef
  65. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth
    Henk M. De Feyter et al, 2016, Neuro Oncol CrossRef
  66. Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis
    Rainer J. Klement et al, 2016, PLoS ONE CrossRef
  67. Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study
    Adeleh Khodabakhshi et al, 2019, Nutrition and Cancer CrossRef
  68. Management of glioblastoma after recurrence: A changing paradigm
    Supriya Mallick et al, 2016, Journal of the Egyptian National Cancer Institute CrossRef
  69. mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling
    Kenta Masui et al, 2016, BioEssays CrossRef
  70. Ketogene Ernährungstherapie – Formen und Anwendungsgebiete
    Alexander Höller et al, 2016, Paediatr. Paedolog. Austria CrossRef
  71. ESPEN guidelines on nutrition in cancer patients
    Jann Arends et al, 2017, Clinical Nutrition CrossRef
  72. Ketogenic diet and childhood neurological disorders other than epilepsy: an overview
    Alberto Verrotti et al, 2017, Expert Review of Neurotherapeutics CrossRef
  73. Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials
    Gelina S. Kopeina et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  74. null
    Kalil G. Abdullah et al, 2016 CrossRef
  75. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
    Thomas N. Seyfried et al, 2017, Nutr Metab (Lond) CrossRef
  76. Adjuvant metabolic therapy for glioblastoma multiform
    Hailey D. Weeks et al, 2017, Clinical Nutrition ESPEN CrossRef
  77. Restoring Balance for People with Cancer Through Integrative Oncology
    Judy A. Fulop et al, 2017, Primary Care: Clinics in Office Practice CrossRef
  78. Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation
    Rainer J. Klement, 2017, Med Oncol CrossRef
  79. Underweight and weight loss are predictors of poor outcome in patients with brain metastasis
    Anna Lareida et al, 2019, J Neurooncol CrossRef
  80. Complementary and alternative medicine use in glioma patients in France
    Emilie Le Rhun et al, 2019, J Neurooncol CrossRef
  81. Ketogenic diets in medical oncology: a systematic review with focus on clinical outcomes
    Rainer J. Klement et al, 2020, Med Oncol CrossRef
  82. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study
    Kirsty J. Martin-McGill et al, 2020, J Neurooncol CrossRef
  83. Role of the ketogenic diet in acute neurological diseases
    Niraj Arora et al, 2020, Clinical Neurology and Neurosurgery CrossRef
  84. The Ketogenic Diet all Grown Up – Ketogenic Diet Therapies for adults
    Khalil S. Husari et al, 2020, Epilepsy Research CrossRef
  85. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
    Thomas N. Seyfried et al, 2020, Front. Nutr. CrossRef
  86. null
    Atiqur Rahman et al, 2020 CrossRef
  87. Addressing the controversial role of ketogenic diets in cancer treatment
    Rainer Johannes Klement, 2020, Expert Review of Anticancer Therapy CrossRef
  88. The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome
    Silvia Vidali et al, 2017, Oncotarget CrossRef
  89. A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model
    Sepideh Aminzadeh-Gohari et al, 2017, Oncotarget CrossRef
  90. Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
    Raphael Johannes Morscher et al, 2016, Oncotarget CrossRef
  91. Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy
    Dieter Lemke et al, 2016, Oncotarget CrossRef
  92. null
    Santhosshi Narayanan et al, 2020 CrossRef
  93. Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review
    Philippe Icard et al, 2020 CrossRef
  94. Metabolic heterogeneity and adaptability in brain tumors
    Christian E. Badr et al, 2020, Cell. Mol. Life Sci. CrossRef
  95. Isocaloric Ketogenic Diet in Adults with High-Grade Gliomas: A Prospective Metabolic Study
    Andrea Foppiani et al, 2020, Nutrition and Cancer CrossRef
  96. Does nutrition for cancer patients feed the tumour? A clinical perspective
    F. Bozzetti et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
  97. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production
    Chen‑Chen Ji et al, 2019, Int J Oncol CrossRef
  98. Ketogenic Diet for Malignant Gliomas: a Review
    Jonathan G. Thomas et al, 2020, Curr Nutr Rep CrossRef
  99. ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
    Martin Voss et al, 2020, International Journal of Radiation Oncology*Biology*Physics CrossRef
  100. null
    Daniel Wahl et al, 2020 CrossRef
  101. Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
    Jantzen Sperry et al, 2020, iScience CrossRef
  102. MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet
    Emilio Ciusani et al, 2020, Nutrition and Cancer CrossRef
  103. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
    Ellen C. de Heer et al, 2020 CrossRef
  104. Ketogenic diet: a tool for the management of neuroendocrine neoplasms?
    Giovanna Muscogiuri et al, 2020, Critical Reviews in Food Science and Nutrition CrossRef
  105. Effectiveness of Ketogenic Diets on the Survival of Adult Oncological Patients
    Simona Minzer, 2020, Nutrition and Cancer CrossRef
  106. Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
    Yannick Braun et al, 2020, Neuropathol Appl Neurobiol CrossRef
  107. Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement
    Pavel Klein et al, 2020, Cancer Metab CrossRef
  108. Energy and caloric restriction, and fasting and cancer: a narrative review
    Ezzeldin M. Ibrahim et al, 2020, Support Care Cancer CrossRef
  109. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature
    Nicola Montemurro et al, 2020, IJERPH CrossRef
  110. Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial
    Katharina J. Wenger et al, 2020, Cancers CrossRef
  111. Could ketogenic diet “starve” cancer? Emerging evidence
    Luigi Barrea et al, 2020, Critical Reviews in Food Science and Nutrition CrossRef
  112. Le régime cétogène : une stratégie alimentaire efficace en complément des traitements contre le cancer ?
    Anouk Charlot et al, 2020, Biologie Aujourd’hui CrossRef
  113. The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology
    Catherine J. Libby et al, 2020, Cancer Res CrossRef
  114. A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma
    Regina T. Martuscello et al, 2016, Clin Cancer Res CrossRef
  115. Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
    Masahiro Maeyama et al, 2021, Sci Rep CrossRef
  116. A ketogenic diet consumed during radiotherapy improves several aspects of quality of life and metabolic health in women with breast cancer
    Rainer J. Klement et al, 2021, Clinical Nutrition CrossRef
  117. Contourner la résistance à l’immunothérapie des cancers : interventions centrées sur le microbiome intestinal
    M. Fidelle et al, 2021, Bulletin de l'Académie Nationale de Médecine CrossRef
  118. Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging
    Winnie M.C. van den Boogaard et al, 2021, Annu. Rev. Cancer Biol. CrossRef
  119. ESPEN practical guideline: Clinical Nutrition in cancer
    Maurizio Muscaritoli et al, 2021, Clinical Nutrition CrossRef
  120. The use of ketogenic diets in cancer patients: a systematic review
    Maximilian Römer et al, 2021, Clin Exp Med CrossRef
  121. Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review
    Sarah Travers et al, 2021, Brain Sciences CrossRef
  122. Ketojenik Diyet ve Kanser
    Hatice Kübra YILMAZ et al, 2021 CrossRef
  123. Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles
    Dhiraj J. Pangal et al, 2021, World Neurosurgery CrossRef
  124. Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
    Thomas N. Seyfried et al, 2021, Front. Nutr. CrossRef
  125. Cancer Treatment With the Ketogenic Diet: A Systematic Review and Meta-analysis of Animal Studies
    Jing Li et al, 2021, Front. Nutr. CrossRef
  126. Ketogenic diets consumed during radio-chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancer
    Rainer J. Klement et al, 2021, Eur J Nutr CrossRef
  127. A Clinical Perspective of Low Carbohydrate Ketogenic Diets: A Narrative Review
    Samir Giuseppe Sukkar et al, 2021, Front. Nutr. CrossRef
  128. Amino acid metabolism as a therapeutic target in cancer: a review
    Molly Endicott et al, 2021, Amino Acids CrossRef
  129. A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?
    Liliana Montella et al, 2021, Front. Nutr. CrossRef
  130. Ketogenic Diet with Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma: Preclinical and Phase 1 Trial Results
    Daniel C. Ma et al, 2021, Radiation Research CrossRef
  131. Implementation of a Low-Carbohydrate Diet Improves the Quality of Life of Cancer Patients – An Online Survey
    Julia Tulipan et al, 2021, Front. Nutr. CrossRef
  132. Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma
    Karisa C. Schreck et al, 2021, Neurology CrossRef
  133. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer
    Joshua J Meidenbauer et al, 2015, Nutr Metab (Lond) CrossRef
  134. A map of the altered glioma metabolism
    Ruhi Deshmukh et al, 2021, Trends in Molecular Medicine CrossRef
  135. Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial
    Martin Voss et al, 2021, Eur J Nutr CrossRef
  136. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
    Natalia E. Cortez et al, 2021, Nutrients CrossRef
  137. Ketogenic Diet for Cancer: Critical Assessment and Research Recommendations
    Jordin Lane et al, 2021, Nutrients CrossRef
  138. Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma
    Taiana Campos Leite et al, 2021, J Transl Med CrossRef
  139. null
    Rajesh N. Gacche, 2021 CrossRef
  140. Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer
    Mehmet Salih Iyikesici, 2020, Complement Med Res CrossRef
  141. A dieta cetogênica pode auxiliar no tratamento do câncer? Uma análise crítica
    Fabiana Neves Figueiredo et al, 2020, R. Assoc. bras. Nutr. CrossRef